ES552145A0 - Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico. - Google Patents

Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico.

Info

Publication number
ES552145A0
ES552145A0 ES552145A ES552145A ES552145A0 ES 552145 A0 ES552145 A0 ES 552145A0 ES 552145 A ES552145 A ES 552145A ES 552145 A ES552145 A ES 552145A ES 552145 A0 ES552145 A0 ES 552145A0
Authority
ES
Spain
Prior art keywords
oral administration
manufacturing procedure
dosing unit
potassic
chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES552145A
Other languages
English (en)
Other versions
ES8801121A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Key Pharmaceuticals Inc
Original Assignee
Key Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Key Pharmaceuticals Inc filed Critical Key Pharmaceuticals Inc
Publication of ES552145A0 publication Critical patent/ES552145A0/es
Publication of ES8801121A1 publication Critical patent/ES8801121A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
ES552145A 1985-02-19 1986-02-18 Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico. Expired ES8801121A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70271485A 1985-02-19 1985-02-19

Publications (2)

Publication Number Publication Date
ES552145A0 true ES552145A0 (es) 1988-01-01
ES8801121A1 ES8801121A1 (es) 1988-01-01

Family

ID=24822313

Family Applications (1)

Application Number Title Priority Date Filing Date
ES552145A Expired ES8801121A1 (es) 1985-02-19 1986-02-18 Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico.

Country Status (13)

Country Link
EP (1) EP0211946B1 (es)
JP (1) JPH0625064B2 (es)
AU (1) AU583903B2 (es)
DE (1) DE3671373D1 (es)
DK (1) DK165123C (es)
ES (1) ES8801121A1 (es)
FI (1) FI87528C (es)
GR (1) GR860479B (es)
IE (1) IE59066B1 (es)
NZ (1) NZ215241A (es)
SG (1) SG120392G (es)
WO (1) WO1986004817A1 (es)
ZA (1) ZA861242B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704285A (en) * 1985-11-18 1987-11-03 The Dow Chemical Company Sustained release compositions comprising hydroxypropyl cellulose ethers
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
US5009897A (en) * 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
IE63242B1 (en) * 1988-06-24 1995-04-05 Abbott Lab Pharmaceutical granules and tablets made therefrom
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
DE9190107U1 (de) * 1990-08-07 1993-12-16 Pfizer Inc., New York, N.Y. Abgabe-Vorrichtung mit durch Grenzflächen-Polymerisation erhaltenen Membranen
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US5397574A (en) * 1993-10-04 1995-03-14 Andrx Pharmaceuticals, Inc. Controlled release potassium dosage form
US5458888A (en) * 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation
DK1067910T3 (da) 1998-04-03 2004-10-04 Egalet As Komposition med styret afgivelse
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
WO2003024429A1 (en) 2001-09-21 2003-03-27 Egalet A/S Polymer release system
WO2004041252A1 (en) 2002-11-08 2004-05-21 Egalet A/S Controlled release carvedilol compositions
US8877241B2 (en) 2003-03-26 2014-11-04 Egalet Ltd. Morphine controlled release system
DE602004014747D1 (de) 2003-03-26 2008-08-14 Egalet As Matrixzubereitungen für die kontrollierte darreichung von arzneistoffen
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
JP2015521988A (ja) 2012-07-06 2015-08-03 イガレット・リミテッド 制御放出用乱用防止性医薬組成物
FR3069545B1 (fr) 2017-07-27 2020-10-16 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition d'enrobage exempte de dioxyde de titane

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259315A (en) * 1980-06-13 1981-03-31 A. H. Robins Company, Inc. Controlled release potassium dosage form
EP0052076B1 (de) * 1980-11-12 1985-05-29 Ciba-Geigy Ag Schnellzerfallende Arzneimittel-Presslinge
WO1984000004A1 (en) * 1982-06-14 1984-01-05 Key Pharma Sustained release aspirin
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.

Also Published As

Publication number Publication date
JPS62501845A (ja) 1987-07-23
FI87528B (fi) 1992-10-15
WO1986004817A1 (en) 1986-08-28
IE59066B1 (en) 1993-12-15
FI864207L (fi) 1986-10-17
EP0211946B1 (en) 1990-05-23
DK494986D0 (da) 1986-10-16
DE3671373D1 (de) 1990-06-28
IE860433L (en) 1986-08-19
GR860479B (en) 1986-06-18
ZA861242B (en) 1986-10-29
AU583903B2 (en) 1989-05-11
ES8801121A1 (es) 1988-01-01
EP0211946A1 (en) 1987-03-04
DK494986A (da) 1986-10-16
DK165123C (da) 1993-03-01
NZ215241A (en) 1988-10-28
JPH0625064B2 (ja) 1994-04-06
SG120392G (en) 1993-01-29
FI864207A0 (fi) 1986-10-17
AU5514086A (en) 1986-09-10
FI87528C (fi) 1993-01-25

Similar Documents

Publication Publication Date Title
DE3681348D1 (de) Oral-arzneizubereitung mit retardwirkung.
FI863709A0 (fi) Oral sammansaettning som foerhindrar bildande av tandsten.
FI862479L (fi) Oral farmaceutisk komposition.
NO863652D0 (no) Oralt preparat mot tannstein.
DK35287D0 (da) Stabilt, oralt, enkelt enhedsdosisprodukt
LV5760A4 (lv) Jauns farmaceitisks preparats peroralai lietosanai
FI870140A7 (fi) Oraaliset rokotteet.
MX9202976A (es) Una preparacion de etoposido.
DK175487A (da) Farmaceutisk aktive 2-thiomethyl-substitueret-1,4-dihydro-pyridiner
DK520283A (da) Vandig, oral oploesning
ES557670A0 (es) Un procedimiento para la produccion de una preparacion de activador de proteina c.
FI863077L (fi) Farmaceutisk dosenhet.
ES554812A0 (es) Un procedimiento para preparar una composicion anticariogena solida para administracion oral.
IT8619496A0 (it) Spazzolino interdentale.
KR880700906A (ko) 치합기구에서의 치형
MX9203559A (es) Una forma de dosificacion para administrar clorofeniramina.
FI864880L (fi) Mundhygienbehandlingsplats.
ES1000119Y (es) Una tableta farmaceutica para administracion oral
ES556000A0 (es) Un procedimiento para la preparacion de una serie de piridazinas
ES553705A0 (es) Un procedimiento para la preparacion de una alcanoilanilida
IT1190483B (it) Procedimento di preparazione di una fenilurea sostituita
DK303886D0 (da) Aktive forbindelser
ES541400A0 (es) Una tableta fumigante
ES551634A0 (es) Procedimiento para la preparacion de una composicion farmaceutica a base de 3-aminopropoxiindoles
DK111786D0 (da) Oralt middel mod tandsten

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040929